middle.news
Radiopharm Unveils $40M Equity Raise to Power Oncology Trials
6:02pm on Monday 20th of October, 2025 AEDT
•
Healthcare
Read Story
Radiopharm Unveils $40M Equity Raise to Power Oncology Trials
6:02pm on Monday 20th of October, 2025 AEDT
Key Points
Equity raise targets $40 million through placement and SPP
New shares priced at $0.03 with free attaching options exercisable at $0.039
Funds earmarked for clinical trials, drug manufacturing, and working capital
Shareholder approval required for second tranche and options issuance
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Radiopharm Theranostics (ASX:RAD)
OPEN ARTICLE